- Home
- RCKT vs DFIN Comparison
RCKT vs DFIN Comparison
Compare RCKT & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- DFIN
- Stock Information
- Founded
- RCKT 1999
- DFIN 1983
- Country
- RCKT United States
- DFIN United States
- Employees
- RCKT N/A
- DFIN N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- DFIN Other Consumer Services
- Sector
- RCKT Health Care
- DFIN Consumer Discretionary
- Exchange
- RCKT Nasdaq
- DFIN Nasdaq
- Market Cap
- RCKT 264.0M
- DFIN 1.8B
- IPO Year
- RCKT N/A
- DFIN N/A
- Fundamental
- Price
- RCKT $2.81
- DFIN $61.87
- Analyst Decision
- RCKT Buy
- DFIN Strong Buy
- Analyst Count
- RCKT 13
- DFIN 3
- Target Price
- RCKT $18.50
- DFIN $68.67
- AVG Volume (30 Days)
- RCKT 3.6M
- DFIN 228.5K
- Earning Date
- RCKT 08-04-2025
- DFIN 07-30-2025
- Dividend Yield
- RCKT N/A
- DFIN N/A
- EPS Growth
- RCKT N/A
- DFIN N/A
- EPS
- RCKT N/A
- DFIN 3.01
- Revenue
- RCKT N/A
- DFIN $779,600,000.00
- Revenue This Year
- RCKT N/A
- DFIN $1.99
- Revenue Next Year
- RCKT N/A
- DFIN $4.64
- P/E Ratio
- RCKT N/A
- DFIN $20.66
- Revenue Growth
- RCKT N/A
- DFIN N/A
- 52 Week Low
- RCKT $2.19
- DFIN $37.80
- 52 Week High
- RCKT $26.98
- DFIN $71.01
- Technical
- Relative Strength Index (RSI)
- RCKT 41.85
- DFIN 66.23
- Support Level
- RCKT $2.76
- DFIN $63.34
- Resistance Level
- RCKT $3.24
- DFIN $66.25
- Average True Range (ATR)
- RCKT 0.19
- DFIN 1.17
- MACD
- RCKT 0.13
- DFIN -0.14
- Stochastic Oscillator
- RCKT 49.10
- DFIN 55.31
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.